4
Changes in Ownership
ACADIA PHARMACEUTICALS INC Filed Acc 0001415889-25-010424
EVP, CHIEF FINANCIAL OFFICER sold 2,708 shares at $14.82 ($40,133)
- EVP, CHIEF FINANCIAL OFFICER acquired 5,275 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER | 2025-04-05 | Option exercise | +5,275 | 62,164 | D | ||
| Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER | 2025-04-08 | Sale | −2,708 | $14.82 | $40,133 | 59,456 | D |
| Derivatives | |||||||
| Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER | 2025-04-05 | Option exercise · Restricted Stock Units | −5,275 | 5,276 | D | ||
| Open-market sales · 2,708 sh · avg $14.82 · $40,133 | |||||||
Loading xslF345X05/form4-04082025_110409.xml…